Publikationen, an denen er mitarbeitet Javier Gómez Ambrosi (8)

2023

  1. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2020

  1. Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 1, pp. 21-37

2019

  1. Circulating concentrations of GDF11 are positively associated with TSH levels in humans

    Journal of Clinical Medicine, Vol. 8, Núm. 6

2012

  1. The ghrelin O-Acyltransferase-Ghrelin system reduces TNF-α-Induced apoptosis and autophagy in human visceral adipocytes

    Diabetologia, Vol. 55, Núm. 11, pp. 3038-3050

2008

  1. Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats

    Life Sciences, Vol. 83, Núm. 15-16, pp. 540-549

2007

  1. Plasma osteopontin levels and expression in adipose tissue are increased in obesity

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 9, pp. 3719-3727

  2. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism

    Endocrinology, Vol. 148, Núm. 1, pp. 324-331

2006

  1. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats

    Journal of Hypertension, Vol. 24, Núm. 8, pp. 1589-1597